Cynvec's Unattributed - III Round

Cynvec raised a round of funding on December 07, 2015.

Cynvec is an oncology focused biotechnology company developing its proprietary oncolytic Sindbis viral vector technology as a differentiated and transformational platform for the treatment of cancer. …

Articles about Cynvec's Unattributed - III Round: